Charles Schwab’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16
| Closed | -$42K | – | 3564 |
|
|
2021
Q2 | $42K | Sell |
16
-74
| -82% | -$194K | ﹤0.01% | 3394 |
|
|
2021
Q1 | $376K | Buy |
90
+4
| +5% | +$16.7K | ﹤0.01% | 3176 |
|
|
2020
Q4 | $495K | Hold |
86
| – | – | ﹤0.01% | 2997 |
|
|
2020
Q3 | $524K | Sell |
86
-3
| -3% | -$18.3K | ﹤0.01% | 2864 |
|
|
2020
Q2 | $494K | Buy |
+89
| New | +$494K | ﹤0.01% | 2833 |
|
|
2017
Q2 | – | Sell |
-7
| Closed | -$44K | – | 3153 |
|
|
2017
Q1 | $44K | Hold |
7
| – | – | ﹤0.01% | 3042 |
|
|
2016
Q4 | $77K | Hold |
7
| – | – | ﹤0.01% | 3054 |
|
|
2016
Q3 | $94K | Hold |
7
| – | – | ﹤0.01% | 3014 |
|
|
2016
Q2 | $103K | Hold |
7
| – | – | ﹤0.01% | 3051 |
|
|
2016
Q1 | $84K | Hold |
7
| – | – | ﹤0.01% | 3000 |
|
|
2015
Q4 | $132K | Hold |
7
| – | – | ﹤0.01% | 3022 |
|
|
2015
Q3 | $91K | Hold |
7
| – | – | ﹤0.01% | 3043 |
|
|
2015
Q2 | $116K | Buy |
+7
| New | +$116K | ﹤0.01% | 3040 |
|